These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18361932)

  • 21. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
    Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma.
    Shang ZJ; Li JR; Li ZB
    J Oral Maxillofac Surg; 2007 Jan; 65(1):17-21. PubMed ID: 17174758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
    Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
    J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the negative node count affect disease-free survival in early-stage oral cavity cancer?
    Ampil FL; Caldito G; Ghali GE; Baluna RG
    J Oral Maxillofac Surg; 2009 Nov; 67(11):2473-5. PubMed ID: 19837320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma.
    Lu CC; Chang KW; Chou FC; Cheng CY; Liu CJ
    Oral Oncol; 2007 Mar; 43(3):283-8. PubMed ID: 16920387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class I chain-related gene a diversity in head and neck squamous cell carcinoma.
    Reinders J; Rozemuller EH; van der Ven KJ; Caillat-Zucman S; Slootweg PJ; de Weger RA; Tilanus MG
    Hum Immunol; 2006 Mar; 67(3):196-203. PubMed ID: 16698442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of major histocompatibility complex class I-related chain A/B (MICA/B) in pancreatic carcinoma.
    Dambrauskas Z; Svensson H; Joshi M; Hyltander A; Naredi P; Iresjö BM
    Int J Oncol; 2014 Jan; 44(1):99-104. PubMed ID: 24173243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection.
    Suárez-Alvarez B; López-Vázquez A; Díaz-Molina B; Bernardo-Rodríguez MJ; Alvarez-López R; Pascual D; Astudillo A; Martínez-Borra J; Lambert JL; González S; López-Larrea C
    Transplantation; 2006 Aug; 82(3):354-61. PubMed ID: 16906033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage treatment for recurrent oral squamous cell carcinoma.
    Sun GW; Tang EY; Yang XD; Hu QG
    J Craniofac Surg; 2009 Jul; 20(4):1093-6. PubMed ID: 19521259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
    Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.
    Chen CH; Tsai TL; Yang YS; Tsai CC
    J Oral Pathol Med; 2007 Feb; 36(2):83-7. PubMed ID: 17238969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral squamous sell carcinoma in North-Eastern Hungary I. Epidemiology].
    Nemes J; Redl P; Boda R; Márton I
    Fogorv Sz; 2006 Aug; 99(4):161-7. PubMed ID: 17016924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients.
    Tamaki S; Sanefuzi N; Ohgi K; Imai Y; Kawakami M; Yamamoto K; Ishitani A; Hatake K; Kirita T
    J Oral Pathol Med; 2007 Jul; 36(6):351-6. PubMed ID: 17559497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases.
    Arduino PG; Carrozzo M; Chiecchio A; Broccoletti R; Tirone F; Borra E; Bertolusso G; Gandolfo S
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1570-9. PubMed ID: 18634942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of heat shock protein 27 is associated with good prognosis in the patient with oral squamous cell carcinoma.
    Suzuki H; Sugimura H; Hashimoto K
    Br J Oral Maxillofac Surg; 2007 Mar; 45(2):123-9. PubMed ID: 16720063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.